263 related articles for article (PubMed ID: 21123374)
1. A systematic analysis of human papillomavirus (HPV) E6 PDZ substrates identifies MAGI-1 as a major target of HPV type 16 (HPV-16) and HPV-18 whose loss accompanies disruption of tight junctions.
Kranjec C; Banks L
J Virol; 2011 Feb; 85(4):1757-64. PubMed ID: 21123374
[TBL] [Abstract][Full Text] [Related]
2. Restoration of MAGI-1 expression in human papillomavirus-positive tumor cells induces cell growth arrest and apoptosis.
Kranjec C; Massimi P; Banks L
J Virol; 2014 Jul; 88(13):7155-69. PubMed ID: 24696483
[TBL] [Abstract][Full Text] [Related]
3. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
[TBL] [Abstract][Full Text] [Related]
4. Molecular insights into the interaction of HPV-16 E6 variants against MAGI-1 PDZ1 domain.
Araujo-Arcos LE; Montaño S; Bello-Rios C; Garibay-Cerdenares OL; Leyva-Vázquez MA; Illades-Aguiar B
Sci Rep; 2022 Feb; 12(1):1898. PubMed ID: 35115618
[TBL] [Abstract][Full Text] [Related]
5. Surface plasmon resonance analysis of the binding of high-risk mucosal HPV E6 oncoproteins to the PDZ1 domain of the tight junction protein MAGI-1.
Fournane S; Charbonnier S; Chapelle A; Kieffer B; Orfanoudakis G; Travé G; Masson M; Nominé Y
J Mol Recognit; 2011; 24(4):511-23. PubMed ID: 20842623
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional characterization of the PDZ domain of the human phosphatase PTPN3 and its interaction with the human papillomavirus E6 oncoprotein.
Genera M; Samson D; Raynal B; Haouz A; Baron B; Simenel C; Guerois R; Wolff N; Caillet-Saguy C
Sci Rep; 2019 May; 9(1):7438. PubMed ID: 31092861
[TBL] [Abstract][Full Text] [Related]
7. Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein.
Zhang Y; Dasgupta J; Ma RZ; Banks L; Thomas M; Chen XS
J Virol; 2007 Apr; 81(7):3618-26. PubMed ID: 17267502
[TBL] [Abstract][Full Text] [Related]
8. Acquisition of a phospho-acceptor site enhances HPV E6 PDZ-binding motif functional promiscuity.
Sarabia-Vega V; Banks L
J Gen Virol; 2020 Sep; 101(9):954-962. PubMed ID: 30810519
[TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus E6 interaction with cellular PDZ domain proteins modulates YAP nuclear localization.
Webb Strickland S; Brimer N; Lyons C; Vande Pol SB
Virology; 2018 Mar; 516():127-138. PubMed ID: 29346075
[TBL] [Abstract][Full Text] [Related]
10. Analysis of specificity determinants in the interactions of different HPV E6 proteins with their PDZ domain-containing substrates.
Thomas M; Dasgupta J; Zhang Y; Chen X; Banks L
Virology; 2008 Jul; 376(2):371-8. PubMed ID: 18452965
[TBL] [Abstract][Full Text] [Related]
11. PATJ, a tight junction-associated PDZ protein, is a novel degradation target of high-risk human papillomavirus E6 and the alternatively spliced isoform 18 E6.
Storrs CH; Silverstein SJ
J Virol; 2007 Apr; 81(8):4080-90. PubMed ID: 17287269
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance.
Nicolaides L; Davy C; Raj K; Kranjec C; Banks L; Doorbar J
Virology; 2011 Jun; 414(2):137-45. PubMed ID: 21489588
[TBL] [Abstract][Full Text] [Related]
13. Roles of the PDZ domain-binding motif of the human papillomavirus type 16 E6 on the immortalization and differentiation of primary human foreskin keratinocytes.
Choi M; Lee S; Choi T; Lee C
Virus Genes; 2014 Apr; 48(2):224-32. PubMed ID: 24293186
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 8 E6 oncoprotein inhibits transcription of the PDZ protein syntenin-2.
Lazić D; Hufbauer M; Zigrino P; Buchholz S; Kazem S; Feltkamp MC; Mauch C; Steger G; Pfister H; Akgül B
J Virol; 2012 Aug; 86(15):7943-52. PubMed ID: 22623796
[TBL] [Abstract][Full Text] [Related]
15. PDZ domains and viral infection: versatile potentials of HPV-PDZ interactions in relation to malignancy.
Nagasaka K; Kawana K; Osuga Y; Fujii T
Biomed Res Int; 2013; 2013():369712. PubMed ID: 24093094
[TBL] [Abstract][Full Text] [Related]
16. HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation.
Thomas M; Glaunsinger B; Pim D; Javier R; Banks L
Oncogene; 2001 Sep; 20(39):5431-9. PubMed ID: 11571640
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand.
Ramirez J; Poirson J; Foltz C; Chebaro Y; Schrapp M; Meyer A; Bonetta A; Forster A; Jacob Y; Masson M; Deryckère F; Travé G
Angew Chem Int Ed Engl; 2015 Jun; 54(27):7958-62. PubMed ID: 26014966
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus (HPV)-18 E6 oncoprotein interferes with the epithelial cell polarity Par3 protein.
Facciuto F; Bugnon Valdano M; Marziali F; Massimi P; Banks L; Cavatorta AL; Gardiol D
Mol Oncol; 2014 May; 8(3):533-43. PubMed ID: 24462519
[TBL] [Abstract][Full Text] [Related]
19. Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins.
Pim D; Thomas M; Banks L
Oncogene; 2002 Nov; 21(53):8140-8. PubMed ID: 12444549
[TBL] [Abstract][Full Text] [Related]
20. Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity.
Thatte J; Banks L
J Virol; 2017 Nov; 91(22):. PubMed ID: 28835500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
